(HealthDay)—The TIMI (Thrombolysis in Myocardial Infarction) Risk Score for Secondary Prevention (TRS 2°P) is an accurate predictor of atherothrombotic disease among patients with type 2 diabetes, according to a study ...
Dec 15, 2017
0
7
(HealthDay)—For patients with peripheral arterial disease who are discharged following peripheral arterial revascularization, 17.6 percent have 30-day nonelective readmission, according to a study published online Dec. ...
Dec 5, 2017
0
0
While traffic-related air pollution is common worldwide and is the source of many health problems, little is known about its impact on vascular health, particularly among people with cardiovascular disease.
Dec 1, 2017
0
0
A stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements, according to the results of a new Northwestern Medicine clinical trial.
Nov 15, 2017
0
13
While patients who are discharged from the hospital after treatment for heart disease, cerebrovascular disease, or peripheral artery disease, should be on statin medications to reduce their risk of reoccurrence, very few ...
Nov 14, 2017
0
1
If you have a heart attack or stroke, it's important to get your "bad" cholesterol measured by your doctor on a follow up visit. Researchers have found that one step is significantly associated with a reduced risk of suffering ...
Nov 13, 2017
0
13
Stem cell researchers at Emory University School of Medicine have made an advance toward having a long-lasting "repair caulk" for blood vessels. The research could form the basis of a treatment for peripheral artery disease, ...
Oct 23, 2017
0
31
Smoking and diabetes are the two leading risk factors for peripheral artery disease (PAD), a narrowing of the arteries which can result in amputation, according to a study carried out at the University of Dundee and part-funded ...
Sep 19, 2017
0
0
A novel screening programme for vascular disease saves one life for every 169 men assessed, according to late-breaking results from the VIVA trial presented today in a Hot Line LBCT Session at ESC Congress and published in ...
Aug 28, 2017
0
0
A major international study has found that the combination of two drugs - rivaroxaban and aspirin—is superior to aspirin alone in preventing further heart complications in people with vascular disease.
Aug 28, 2017
0
2
